GSA Capital Partners’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-28,260
| Closed | -$255K | – | 1858 |
|
|
2024
Q1 | $255K | Buy |
28,260
+2,219
| +9% | +$20K | 0.02% | 1297 |
|
|
2023
Q4 | $247K | Buy |
+26,041
| New | +$247K | 0.02% | 1212 |
|
|
2023
Q2 | – | Sell |
-9,764
| Closed | -$306K | – | 1746 |
|
|
2023
Q1 | $306K | Buy |
+9,764
| New | +$306K | 0.03% | 1016 |
|
|
2022
Q4 | – | Sell |
-4,269
| Closed | -$368K | – | 1690 |
|
|
2022
Q3 | $368K | Buy |
4,269
+1,736
| +69% | +$150K | 0.05% | 797 |
|
|
2022
Q2 | $209K | Buy |
+2,533
| New | +$209K | 0.03% | 1051 |
|
|
2021
Q3 | – | Sell |
-8,892
| Closed | -$483K | – | 1617 |
|
|
2021
Q2 | $483K | Sell |
8,892
-361
| -4% | -$19.6K | 0.05% | 652 |
|
|
2021
Q1 | $551K | Sell |
9,253
-1,809
| -16% | -$108K | 0.09% | 299 |
|
|
2020
Q4 | $577K | Buy |
11,062
+4,780
| +76% | +$249K | 0.09% | 345 |
|
|
2020
Q3 | $304K | Buy |
+6,282
| New | +$304K | 0.05% | 719 |
|
|
2019
Q4 | – | Sell |
-4,237
| Closed | -$139K | – | 1592 |
|
|
2019
Q3 | $139K | Buy |
+4,237
| New | +$139K | 0.02% | 1237 |
|